Risk-stratification of lung cancer using buccal nanocytology

H. Subramanian*, P. Viswanathan, R. Iyengar, L. Cherkezyan, M. Verleye, S. Rozhok, A. Gandhi, J. Derbas, J. Czarnecki, H. K. Roy, V. Backman

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Buccal nanocytology is employed in the development of a primary care physician's office based, low cost, minimally intrusive and accurate risk stratification test for lung cancer among current and former smokers.

Original languageEnglish (US)
Title of host publicationClinical and Translational Biophotonics, Translational 2016
PublisherOSA - The Optical Society
ISBN (Print)9781943580101
DOIs
StatePublished - Apr 18 2016
EventClinical and Translational Biophotonics, Translational 2016 - Fort Lauderdale, United States
Duration: Apr 25 2016Apr 28 2016

Publication series

NameOptics InfoBase Conference Papers

Other

OtherClinical and Translational Biophotonics, Translational 2016
CountryUnited States
CityFort Lauderdale
Period4/25/164/28/16

ASJC Scopus subject areas

  • Electronic, Optical and Magnetic Materials
  • Mechanics of Materials

Fingerprint Dive into the research topics of 'Risk-stratification of lung cancer using buccal nanocytology'. Together they form a unique fingerprint.

  • Cite this

    Subramanian, H., Viswanathan, P., Iyengar, R., Cherkezyan, L., Verleye, M., Rozhok, S., Gandhi, A., Derbas, J., Czarnecki, J., Roy, H. K., & Backman, V. (2016). Risk-stratification of lung cancer using buccal nanocytology. In Clinical and Translational Biophotonics, Translational 2016 (Optics InfoBase Conference Papers). OSA - The Optical Society. https://doi.org/10.1364/TRANSLATIONAL.2016.TTh3B.4